Cite
APA Citation
Ngoi, N. Y., Heong, V., Ow, S., Chay, W. Y., Kim, H. S., Choi, C. H., Goss, G., Goh, J. C., Tai, B. C., Lim, D. G., Kaliaperumal, N., Au, V. B., Connolly, J. E., Kim, J., Friedlander, M., Kim, K., & Tan, D. S. (2020). a multicenter phase II randomized trial of durvalumab (MEDI‐4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA). International journal of gynecological cancer, 30(8), . http://access.bl.uk/ark:/81055/vdc_100107609976.0x000010